Bio-Key Stock Financials


USD 1.01  0.04  3.81%   

We have analyzed and interpolated thirty-five available fundamental indicators for Bio-Key Intl, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Bio-Key Intl financials, including its price to book, current ratio, working capital, as well as the relationship between the net income and number of employees . Given that Bio-Key Intl is a hitting penny stock territory we recommend to closely look at its number of shares shorted. Use Bio-Key Intl to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Bio-Key Intl to be traded at $0.9696 in 90 days.
With this module, you can analyze Bio-Key financials for your investing period. You should be able to track the changes in Bio-Key Intl individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Bio-Key Most Recent Estimates

EPS Estimate Next Quarter
Diluted Eps
EPS Estimate Current Year
EPS Estimate Current Quarter
Earnings Share
Understanding current and past Bio-Key Intl Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bio-Key Intl's financial statements are interrelated, with each one affecting the others. For example, an increase in Bio-Key Intl's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 65
Bio-Key Intl has more than 65 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Bio-Key Intl stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Bio-Key Intl's official financial statements usually reflect Bio-Key Intl's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bio-Key Intl. For example, before you start analyzing numbers published by Bio-Key accountants, it's critical to develop an understanding of what Bio-Key Intl's liquidity, profitability, and earnings quality are in the context of the Industrials space in which it operates.
Please note, the presentation of Bio-Key Intl's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio-Key Intl's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bio-Key Intl's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bio-Key Intl. Please utilize our Beneish M Score to check the likelihood of Bio-Key Intl's management to manipulate its earnings.

Bio-Key Intl Company Summary

Bio-Key Intl competes with Secom, Allegion Plc, Securitas, and Securitas. BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business AddressBuilding A
IndustrySecurity & Protection Services
Phone732 359 1100
CurrencyUSD - US Dollar
You should never invest in Bio-Key Intl without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bio-Key Stock, because this is throwing your money away. Analyzing the key information contained in Bio-Key Intl's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Bio-Key Intl Key Financial Ratios

Generally speaking, Bio-Key Intl's financial ratios allow both analysts and investors to convert raw data from Bio-Key Intl's financial statements into concise, actionable information that can be used to evaluate the performance of Bio-Key Intl over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bio-Key Intl reports annually and quarterly.

Bio-Key Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bio-Key Intl's current stock value. Our valuation model uses many indicators to compare Bio-Key Intl value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio-Key Intl competition to find correlations between indicators driving Bio-Key Intl's intrinsic value. More Info.
Bio-Key Intl is rated fifth in cash flow from operations category among related companies. It is rated fourth in price to book category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio-Key Intl by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio-Key Intl's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio-Key Intl's earnings, one of the primary drivers of an investment's value.

Bio-Key Intl Systematic Risk

Bio-Key Intl's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bio-Key Intl volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was eleven with a total number of output elements of fifty. The Beta measures systematic risk based on how returns on Bio-Key Intl correlated with the market. If Beta is less than 0 Bio-Key Intl generally moves in the opposite direction as compared to the market. If Bio-Key Intl Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bio-Key Intl is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bio-Key Intl is generally in the same direction as the market. If Beta > 1 Bio-Key Intl moves generally in the same direction as, but more than the movement of the benchmark.

About Bio-Key Intl Financials

What exactly are Bio-Key Intl Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Bio-Key Intl's income statement, its balance sheet, and the statement of cash flows. Potential Bio-Key Intl investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Bio-Key Intl investors may use each financial statement separately, they are all related. The changes in Bio-Key Intl's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bio-Key Intl's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Bio-Key Intl is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Bio-Key has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Bio-Key Intl November 28, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Bio-Key Intl help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bio-Key Intl. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bio-Key Intl based on widely used predictive technical indicators. In general, we focus on analyzing Bio-Key Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bio-Key Intl's daily price indicators and compare them against related drivers.
Information Ratio(0.16)
Maximum Drawdown32.05
Value At Risk(5.95)
Potential Upside5.0
Continue to Trending Equities. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running Bio-Key Intl price analysis, check to measure Bio-Key Intl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Key Intl is operating at the current time. Most of Bio-Key Intl's value examination focuses on studying past and present price action to predict the probability of Bio-Key Intl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bio-Key Intl's price. Additionally, you may evaluate how the addition of Bio-Key Intl to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Bio-Key Intl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio-Key Intl. If investors know Bio-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio-Key Intl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.9 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Bio-Key Intl is measured differently than its book value, which is the value of Bio-Key that is recorded on the company's balance sheet. Investors also form their own opinion of Bio-Key Intl's value that differs from its market value or its book value, called intrinsic value, which is Bio-Key Intl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio-Key Intl's market value can be influenced by many factors that don't directly affect Bio-Key Intl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio-Key Intl's value and its price as these two are different measures arrived at by different means. Investors typically determine Bio-Key Intl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Key Intl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.